Clinical Trials Directory

Trials / Completed

CompletedNCT01849432

Study of Brain Circuitry in Anxiety Disorders

Probing Amygdalo-Cortical Circuitry in Anxiety Disorders

Status
Completed
Phase
Study type
Observational
Enrollment
42 (actual)
Sponsor
Mclean Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

A diverse body of research has implicated the amygdalo-cortical circuitry in the pathophysiology of anxiety disorders. For example, one model of PTSD posits exaggerated amygdala responsivity to threat-related stimuli as well as deficient top-down modulation of amygdala responses by specific cortical regions, including the pregenual anterior cingulate cortex, subcallosal cortex, and hippocampus. The investigators propose to investigate the pathophysiology of several specific anxiety disorders, Posttraumatic Stress Disorder (PTSD), Panic Disorder (PD), and Specific Phobia(SP), by using cognitive activation paradigms and magnetic resonance imaging (MRI) to probe the function and structure of implicated amygdalo-cortical circuitry.

Detailed description

All candidates for this project will undergo a comprehensive clinical assessment by an investigator trained to administer these instruments. At the MGH fMRI Center in Charlestown or at the Neuroimaging Center at McLean Hospital in Belmont, MA; each subject will undergo a single MRI session lasting approximately 2 hours. After the scanning session, subjects may be asked to make judgments about the facial expressions or the words that were presented.

Conditions

Timeline

Start date
2006-12-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2013-05-08
Last updated
2013-05-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01849432. Inclusion in this directory is not an endorsement.